Drug development for medical innovation

Using a focused research and development strategy, MERK•G has built a highly innovative product pipeline with programs in all phases of preclinical and clinical development. Project candidates are evaluated using stringent scientific and medical criteria, with the key factor being the development of novel therapeutic products.

Compounds offering treatment of multiple diseases

MERK•G pursues product candidates which have the ability to address more than one disease indication. Developing compounds with the potential to treat several disease indications also creates multiple partnering opportunities. MERK•G selectively develops and markets some products independently, while collaborating with partners to achieve optimal advancement in other programs.

Optimal use of resources

The company's strategy optimizes the synergetic use of MERK•G internal capabilities and resources, which has enabled the company to independently advance drug candidates through all stages of drug development. Moreover, MERK•G works closely with a network of renowned scientists, clinical researchers, and industry experts to ensure the optimal product selection and development strategy.